GSK2830371

Catalog No.S7573 Batch:S757305

Print

Technical Data

Formula

C23H29ClN4O2S
Molecular Weight 461.02 CAS No. 1404456-53-6
Solubility (25°C)* In vitro DMSO 92 mg/mL (199.55 mM)
Ethanol 46 mg/mL (99.77 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description GSK2830371 is an orally active, allosteric Wip1 phosphatase inhibitor with IC50 of 6 nM.
Targets
Wip1 phosphatase [1]
(Cell-free assay)
6 nM
In vitro

In the PPM1D-amplified MCF7 breast carcinoma cells, GSK2830371 increases the phosphorylation of multiple Wip1 substrates, including p53 (S15), Chk2 (T68), H2AX (S139) and ATM (S1981). GSK2830371 shows selective antiproliferative activity in a subset of lymphoid cell lines, all of which carry a wild-type TP53 allele. Furthermore, co-treatment of doxorubicin and GSK2830371 results in a synergistic antiproliferative effect in DOHH2 and MX-1 tumor cells. [1]
In vivo

In vivo, GSK2830371 increases phosphorylation of Chk2 (T68) and p53 (S15) and decreases Wip1 protein concentrations in DOHH2 tumors. GSK2830371 (150 mg/kg p.o.) also inhibits the growth of DOHH2 tumor xenografts via inhibition of Wip1. [1]

Protocol (from reference)

Kinase Assay:

[1]
  • In vitro phosphatase assays

    50 μM FDP substrate with compound or DMSO is added at room temperature before addition of 10 nM Wip1 in assay buffer (50 mM TRIS, pH 7.5, 30 mM MgCl2, 0.8 mM CHAPS, 0.05 mg/ml BSA). Fluorescent signal is detected on a Spectramax microplate reader (485/530 nm).
Cell Assay:

[1]
  • Cell lines

    36 TP53 wild-type cells and 25 TP53 mutant cells

  • Concentrations

    ~10 μM

  • Incubation Time

    7 days

  • Method

    Cells are seeded into 96 well plates at 200–400 cells per well and treated with a compound dilution series on day 1. After 7 d, The CellTiter-Glo cell viability assay is used to determine effects on cell growth. Luminescent signal is detected on an EnVision 2104.
Animal Study:

[1]
  • Animal Models

    Female SCID mice bearing DOHH2 tumor xenografts

  • Dosages

    150 mg/kg BID

  • Administration

    p.o.

Selleck's GSK2830371 has been cited by 10 publications

NR2F1 is a barrier to dissemination of early stage breast cancer cells [ Cancer Res, 2022, canres.4145.2021] PubMed: 35471456
NR2F1 is a barrier to dissemination of early-stage breast cancer cells [ Cancer Res, 2022, 82 (12): 2313–2326.] PubMed: None
Substrate spectrum of PPM1D in the cellular response to DNA double-strand breaks [ iScience, 2022, 25(9):104892] PubMed: 36060052
CDK5RAP2 loss-of-function causes premature cell senescence via the GSK3β/β-catenin-WIP1 pathway [ Cell Death Dis, 2021, 13(1):9] PubMed: 34930892
WIP1 Promotes Cancer Stem Cell Properties by Inhibiting p38 MAPK in NSCLC [ Signal Transduct Target Ther, 2020, 15;5(1):36] PubMed: 32296033
[ Oncogene, 2020, ] PubMed: 32848211
Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib. [ Mol Cancer Res, 2020, 10.1158/1541-7786.MCR-19-0507] PubMed: 32229503
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. [ Nat Commun, 2019, 10(1):3790] PubMed: 31439867
DNA Damage Signaling-Induced Cancer Cell Reprogramming as a Driver of Tumor Relapse [ Mol Cell, 2019, 74(4):651-663.e8] PubMed: 30954402
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma [ J Exp Med, 2018, 215(8):2137-2155] PubMed: 30045945

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.